DSM Industrial Chemicals achieves good volume growth
13 Feb '08
1 min read
Feike Sijbesma, Chairman of the DSM Managing Board, commented: 'DSM performed well in 2007 with good sales growth, particularly during the fourth quarter, and strong results in light of the challenges faced by the company during the year. In 2008, we also expect to perform well.'
'DSM is fully on track to meet the objectives set out in the accelerated Vision 2010 strategy. In 2008, we will continue the transition towards a Life Sciences and Materials Sciences company, addressing the needs of tomorrow's society and capable of delivering sustainable growth.'
For the full year 2007, sales from continuing operations increased by 5%. Organic sales growth amounted to 7% (volumes 3%; selling prices 4%); this is 2% above the strategic target of 5%.
Exchange rates on balance had a negative effect of 3%. The volume increase was particularly strong in the Nutrition and Performance Materials clusters.
The Industrial Chemicals cluster succeeded in achieving good volume growth while at the same time passing on the increased feedstock and energy costs in selling prices.
The strongest price increase was realized by the Pharma cluster due to temporary shortages on the market for anti-infectives.